Table 4 Summary of findings for continuation rate of CHW provision of DMPA in several countries of SSA and in some instances, in clinical settings
Continuation rates | ||||||
|---|---|---|---|---|---|---|
Author, country | Mode of outcome measurement | Provider | Number of women, 1st injection | 3 months | 6 months | 9 months |
Weidert et al. [10] Ethiopia | CHW reports | CHW | 8604 | NR | NR | NR |
Okegbe et al. [4] Republic of Benin | CHW reports | CHW | 7997 | NR | NR | NR |
Mwembo et al. [14] Democratic Republic of Congo | CHW reports | CHW | 252 | 94.8% | 92.1% | NR |
Comfort et al. [17] Madagascar | CHW reports | CHW | NR | NA | NA | NA |
Chin-quee et al. [15] Zambia | Client interview | CHW | 253 | 94% | NR | NR |
Hoke et al. [18] Madagascar | CHW reports | CHW | 303 | 96% | NR | NA |
Olawo et al. [23] Kenya | CHW reports | CHW | 832 | 89% | 81% | 68% |
FHI-USAID [24] Senegal | CHW reports | CHW | 308 | 93% | NR | NR |
Krueger et al. [25] Uganda | Client registers | CHW CLINIC | NR NR | 72% NA | 70% 57% | 84% NA |
Prata et al. [21] Ethiopia | Client surveys at enrolment, 13th week and 6 months | CHW CLINIC | 622 440 | 83.7%** 81.6% | 78.8%** 62.3% | NR NR |
Stanback et al. [19] Uganda | Client surveys at enrolment, 13th week | CHW CLINIC | 449 328 | 88% 85% | NR NR | NR NR |
Jacinto et al. [22] Mozambique | Client surveys at enrolment, 13th week and 6 months | CHW (TBA) CHW (APE) | 782 649 | 80% 68.1% | 91.6% 68.6% | NR NR |